Harris Associates’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-12,000
| Closed | -$732K | – | 173 |
|
|
2025
Q1 | $732K | Buy |
+12,000
| New | +$732K | ﹤0.01% | 128 |
|
|
2019
Q3 | – | Sell |
-121,824
| Closed | -$5.53M | – | 131 |
|
|
2019
Q2 | $5.53M | Sell |
121,824
-734,850
| -86% | -$33.3M | 0.01% | 115 |
|
|
2019
Q1 | $40.9M | Sell |
856,674
-6,385,692
| -88% | -$305M | 0.08% | 94 |
|
|
2018
Q4 | $376M | Sell |
7,242,366
-781,743
| -10% | -$40.6M | 0.76% | 47 |
|
|
2018
Q3 | $498M | Sell |
8,024,109
-388,967
| -5% | -$24.1M | 0.78% | 45 |
|
|
2018
Q2 | $466M | Buy |
8,413,076
+7,772,870
| +1,214% | +$430M | 0.75% | 44 |
|
|
2018
Q1 | $40.5M | Buy |
640,206
+148,420
| +30% | +$9.39M | 0.07% | 100 |
|
|
2017
Q4 | $30.1M | Buy |
491,786
+99,905
| +25% | +$6.12M | 0.05% | 102 |
|
|
2017
Q3 | $25M | Buy |
+391,881
| New | +$25M | 0.04% | 106 |
|
|
2015
Q2 | – | Sell |
-14,267
| Closed | -$920K | – | 141 |
|
|
2015
Q1 | $920K | Sell |
14,267
-2,200
| -13% | -$142K | ﹤0.01% | 139 |
|
|
2014
Q4 | $972K | Buy |
16,467
+867
| +6% | +$51.2K | ﹤0.01% | 148 |
|
|
2014
Q3 | $798K | Hold |
15,600
| – | – | ﹤0.01% | 146 |
|
|
2014
Q2 | $757K | Sell |
15,600
-6,000
| -28% | -$291K | ﹤0.01% | 149 |
|
|
2014
Q1 | $1.12M | Sell |
21,600
-8,424
| -28% | -$438K | ﹤0.01% | 144 |
|
|
2013
Q4 | $1.6M | Hold |
30,024
| – | – | ﹤0.01% | 147 |
|
|
2013
Q3 | $1.39M | Sell |
30,024
-4,701
| -14% | -$218K | ﹤0.01% | 143 |
|
|
2013
Q2 | $1.55M | Buy |
+34,725
| New | +$1.55M | ﹤0.01% | 147 |
|